[Oral transmucosal fentanyl citrate for the treatment of breakthrough pain. Results of a non-interventional study (NIS)]
- PMID: 17899213
- DOI: 10.1007/s00482-007-0590-z
[Oral transmucosal fentanyl citrate for the treatment of breakthrough pain. Results of a non-interventional study (NIS)]
Abstract
Background: In a non-interventional study the efficacy and tolerability of oral transmucosal fentanyl citrate (OTFC) was studied in patients with opioid-treated cancer pain suffering from breakthrough pain.
Patients and methods: The prospective multicenter observational trial included 406 patients. For 3-4 months, efficacy of OTFC treatment for breakthrough pain was documented using a numerical analog pain intensity scale (NAS). Further, OTFC therapy was rated and adverse events were recorded.
Results: With application of oral transmucosal fentanyl citrate median pain intensity fell from NAS 8 points at the beginning to NAS 2 points at the end of the study. The median effective dosage was 400 g. Tolerability was rated as good or very good by 87.5% of the patients.
Conclusion: Oral transmucosal fentanyl citrate is a safe and effective treatment for breakthrough pain in chronic cancer-related pain.
Similar articles
-
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.Pain. 1999 Feb;79(2-3):303-12. doi: 10.1016/s0304-3959(98)00179-1. Pain. 1999. PMID: 10068176 Clinical Trial.
-
Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).Pain. 2001 Mar;91(1-2):123-30. doi: 10.1016/s0304-3959(00)00427-9. Pain. 2001. PMID: 11240084 Clinical Trial.
-
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.J Pain Symptom Manage. 2001 Jul;22(1):575-83. doi: 10.1016/s0885-3924(01)00306-2. J Pain Symptom Manage. 2001. PMID: 11516599 Clinical Trial.
-
Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.Clin Drug Investig. 2011;31(9):605-18. doi: 10.2165/11592910-000000000-00000. Clin Drug Investig. 2011. PMID: 21819159 Review.
-
Fentanyl buccal tablet.Drugs Today (Barc). 2008 Jan;44(1):41-54. doi: 10.1358/dot.2008.44.1.1178469. Drugs Today (Barc). 2008. PMID: 18301803 Review.
Cited by
-
[Dose-finding for treatment with a transdermal fentanyl patch : Titration with oral transmucosal fentanyl citrate and morphine sulfate].Schmerz. 2016 Dec;30(6):560-567. doi: 10.1007/s00482-016-0106-9. Schmerz. 2016. PMID: 27072143 Clinical Trial. German.
-
[Rapid release fentanyl administration forms. Comments of the Working Group on Tumor Pain of the German Pain Society].Schmerz. 2013 Feb;27(1):76-80. doi: 10.1007/s00482-013-1292-3. Schmerz. 2013. PMID: 23377349 German.
-
A randomized controlled trial comparing the effect of intravenous, subcutaneous, and intranasal fentanyl for pain management in patients undergoing cesarean section.Adv Biomed Res. 2016 Dec 27;5:198. doi: 10.4103/2277-9175.190989. eCollection 2016. Adv Biomed Res. 2016. PMID: 28217636 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources